RDHL Stock Summary and Trading Ideas (Redhill Biopharma Ltd. - American Depositary Shares | NASDAQ:RDHL)

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Redhill Biopharma Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol RDHL.

As of January 9, 2026, RDHL stock price declined to $1.32 with 7,539 million shares trading.

RDHL has a beta of 2.82, meaning it tends to be more sensitive to market movements. RDHL has a correlation of 0.29 to the broad based SPY ETF.

RDHL has a market cap of $6.72 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, RDHL traded as high as $12.50 and as low as $.26.

RDHL has underperformed the market in the last year with a return of -78.9%, while the SPY ETF gained +18.3%. In the last 3 month period, RDHL fell short of the market, returning -27.5%, while SPY returned +2.8%. However, in the most recent 2 weeks RDHL has outperformed the stock market by returning +14.8%, while SPY returned 0.0%.

RDHL support price is $1.26 and resistance is $1.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RDHL shares will trade within this expected range on the day.